What does APOTHEEK VAN OPROY do?

APOTHEEK VAN OPROY is a pharmacy in Laakdal. Private Limited, started on 9 December 1986, 1 establishment.

What is the address of APOTHEEK VAN OPROY?

The registered office of APOTHEEK VAN OPROY is located at Meir 10, 2430 Laakdal.

Is APOTHEEK VAN OPROY still active?

Yes. According to the CBE (30 October 2026) APOTHEEK VAN OPROY is active, legal situation “Normale toestand”, started on 9 December 1986.

Is APOTHEEK VAN OPROY registered on Peppol?

Yes, APOTHEEK VAN OPROY is registered on the Peppol network with ID 0208:0429982291.

What is the enterprise number of APOTHEEK VAN OPROY?

The enterprise number of APOTHEEK VAN OPROY is BE0429982291.

When was APOTHEEK VAN OPROY founded?

APOTHEEK VAN OPROY was founded on 9 December 1986.

Who are the directors of APOTHEEK VAN OPROY?

According to the 2025 annual accounts, the directors of APOTHEEK VAN OPROY are: FARMA TEAM BV.

Is APOTHEEK VAN OPROY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 1986; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK VAN OPROY make in 2025?

APOTHEEK VAN OPROY posted a profit after taxes of € 147,954 in financial year 2025.

What is the revenue of APOTHEEK VAN OPROY?

As a small company, APOTHEEK VAN OPROY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 447,188.

How much does an employee at APOTHEEK VAN OPROY earn?

The average wage cost per full-time employee at APOTHEEK VAN OPROY was € 67,100 in 2025: staff costs of € 194,660 for 2.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VAN OPROY have?

According to the 2025 annual accounts, APOTHEEK VAN OPROY has 2.9 full-time equivalents (FTE).

APOTHEEK VAN OPROY (Private Limited) - Laakdal

Dossier APOTHEEK VAN OPROY, printed on 30 October 2026 from databakkes.be/en/0429982291/apotheek-van-oproy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2025.

Financials

Financial year 2025

APOTHEEK VAN OPROY from Laakdal, company number BE0429982291, closed financial year 2025 with a result of € 147,954 after tax. For that financial year APOTHEEK VAN OPROY recorded a gross margin of € 447,188 and equity of € 418,126. Compared with financial year 2024, the result moved from € 154,609 to € 147,954. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 418,126

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 147,954

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 191,561

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 93,500 paid out

63 % of the profit went to the shareholders, mostly to FARMA TEAM (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.9

▲ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 194,660

▲ 24% vs 2024

€ 67,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 7,764

▲ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 57,766

▼ 21% vs 2024

€ 15,223 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 189,936

▲ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,722

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 427,372 Gross margin 2022: € 427,372 First fiscal year in the series	€ 426,876 Gross margin 2023: € 426,876 Unchanged (€ 427,372) Unfavourable step	€ 411,793 Gross margin 2024: € 411,793 ▼ 4% vs 2023 (€ 426,876) Unfavourable step	€ 447,188 Gross margin 2025: € 447,188 ▲ 9% vs 2024 (€ 411,793) Favourable step	▲ 9%
Profit after taxes	€ 150,351 Profit after taxes 2022: € 150,351 First fiscal year in the series	€ 174,505 Profit after taxes 2023: € 174,505 ▲ 16% vs 2022 (€ 150,351) Favourable step	€ 154,609 Profit after taxes 2024: € 154,609 ▼ 11% vs 2023 (€ 174,505) Unfavourable step	€ 147,954 Profit after taxes 2025: € 147,954 ▼ 4% vs 2024 (€ 154,609) Unfavourable step	▼ 4%
Equity	€ 664,057 Equity 2022: € 664,057 First fiscal year in the series	€ 363,563 Equity 2023: € 363,563 ▼ 45% vs 2022 (€ 664,057) Unfavourable step	€ 363,671 Equity 2024: € 363,671 Unchanged (€ 363,563) Favourable step	€ 418,126 Equity 2025: € 418,126 ▲ 15% vs 2024 (€ 363,671) Favourable step	▲ 15%
Total debts	€ 469,671 Total debts 2022: € 469,671 First fiscal year in the series	€ 847,273 Total debts 2023: € 847,273 ▲ 80% vs 2022 (€ 469,671) Unfavourable step	€ 429,510 Total debts 2024: € 429,510 ▼ 49% vs 2023 (€ 847,273) Favourable step	€ 391,092 Total debts 2025: € 391,092 ▼ 9% vs 2024 (€ 429,510) Favourable step	▼ 9%
Cash	€ 528,510 Cash 2022: € 528,510 First fiscal year in the series	€ 244,183 Cash 2023: € 244,183 ▼ 54% vs 2022 (€ 528,510) Unfavourable step	€ 249,632 Cash 2024: € 249,632 ▲ 2% vs 2023 (€ 244,183) Favourable step	€ 191,561 Cash 2025: € 191,561 ▼ 23% vs 2024 (€ 249,632) Unfavourable step	▼ 23%
Land & buildings	€ 31,500 Land & buildings 2022: € 31,500 First fiscal year in the series	€ 23,625 Land & buildings 2023: € 23,625 ▼ 25% vs 2022 (€ 31,500) Unchanged	€ 15,750 Land & buildings 2024: € 15,750 ▼ 33% vs 2023 (€ 23,625) Unchanged	€ 7,875 Land & buildings 2025: € 7,875 ▼ 50% vs 2024 (€ 15,750) Unchanged	▼ 50%
Retained profit	€ 645,465 Retained profit 2022: € 645,465 First fiscal year in the series	€ 344,971 Retained profit 2023: € 344,971 ▼ 47% vs 2022 (€ 645,465) Unfavourable step	€ 345,079 Retained profit 2024: € 345,079 Unchanged (€ 344,971) Favourable step	€ 399,534 Retained profit 2025: € 399,534 ▲ 16% vs 2024 (€ 345,079) Favourable step	▲ 16%
Dividend	€ 151,000 Dividend 2022: € 151,000 First fiscal year in the series	€ 475,000 Dividend 2023: € 475,000 ▲ 215% vs 2022 (€ 151,000) Unchanged	€ 154,500 Dividend 2024: € 154,500 ▼ 67% vs 2023 (€ 475,000) Unchanged	€ 93,500 Dividend 2025: € 93,500 ▼ 39% vs 2024 (€ 154,500) Unchanged	▼ 39%
Bank debt	€ 102,657 Bank debt 2022: € 102,657 First fiscal year in the series	€ 87,822 Bank debt 2023: € 87,822 ▼ 14% vs 2022 (€ 102,657) Favourable step	€ 72,859 Bank debt 2024: € 72,859 ▼ 17% vs 2023 (€ 87,822) Favourable step	€ 57,766 Bank debt 2025: € 57,766 ▼ 21% vs 2024 (€ 72,859) Favourable step	▼ 21%
Balance sheet total	€ 1,133,728 Balance sheet total 2022: € 1,133,728 First fiscal year in the series	€ 1,210,835 Balance sheet total 2023: € 1,210,835 ▲ 7% vs 2022 (€ 1,133,728) Unchanged	€ 793,181 Balance sheet total 2024: € 793,181 ▼ 34% vs 2023 (€ 1,210,835) Unchanged	€ 809,218 Balance sheet total 2025: € 809,218 ▲ 2% vs 2024 (€ 793,181) Unchanged	▲ 2%
Employees (FTE)	2.9 Employees (FTE) 2022: 2.9 First fiscal year in the series	2.2 Employees (FTE) 2023: 2.2 ▼ 0.7 vs 2022 (2.9) Unchanged	2.2 Employees (FTE) 2024: 2.2 Unchanged (2.2) Unchanged	2.9 Employees (FTE) 2025: 2.9 ▲ 0.7 vs 2024 (2.2) Unchanged	▲ 0.7

Key figures of APOTHEEK VAN OPROY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAN OPROY?

What happened at APOTHEEK VAN OPROY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 Corrected annual accounts filed for financial year 2025. Source: NBB ↗
2020 FARMA TEAM BV became a director. NBB
Jan 6, 1987 New establishment in Laakdal. KBO
Dec 9, 1986 Start of the company according to the CBE. KBO

In short

From € 150,351 profit in 2022 to € 147,954 profit in 2025.

Paid € 177,980 in corporate taxes since 2022.

Best year ever: 2023, with € 174,505 profit.

On average € 154,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FARMA TEAM 99.9%

The stake of FARMA TEAM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VAN OPROY

Behind APOTHEEK VAN OPROY is FARMA TEAM BV. The shares are held by FARMA TEAM (99.9%).

Directors

According to the 2025 annual accounts

FARMA TEAM BV

Director · represented by Jolle Van Oproy

Also active at: Apotheek Van Oproy-Zammel

since 2020

Shareholders

FARMA TEAM

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Meir 10

2430 Laakdal

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

FARMA TEAM same network

€ 367,312 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0429.982.291

VAT number

BE 0429.982.291

Registered office

Meir 10, 2430 Laakdal

Names & denominations

APOTHEEK VAN OPROY

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 December 1986

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VAN OPROY

Warning lights

Financials

What happened to APOTHEEK VAN OPROY?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions